Abstract
An acute inflammatory response is mounted in response to a stimulus such as tissue damage or the presence of an invading pathogen (1). If this stimulus cannot be removed, then chronic inflammation will develop as classically shown in rheumatoid arthritis (RA). Along with the array of cytokines and chemokines released during inflammation infiltrating macrophages and neutrophils release nitric oxide (NO•), which is involved in killing the offending organism (2,3). Additionally, NO• is known to mediate the inflammatory response by inhibiting or inducing inflammation via a variety of different pathways (4–8). For example, NO• has been shown to activate and inhibit the transcription factor, nuclear factor-kappa B (NF-κB) (9). When NO• activates NF-κB it induces the generation of proinflammatory cytokines such as tumor necrosis factor alpha (TNFα), which are thought to drive the chronic inflammatory response (10). However, NO• can also cause the inhibition of NF-κB by upregulating the production of its inhibitor IκB (11,12). In a similar way, NO• has been shown to inhibit neutrophil adhesion, preventing white blood cells (WBC) from infiltrating the site of inflammation (13). NO• also increases the vascular permeability of the vessel wall so that WBCs can reach the affected tissue (14). The level of NO• produced is thought to determine whether NO• acts as a proinflammatory or antiinflammatory mediator. In many cases, the formation of peroxynitrite, from NO• and superoxide, is thought to be responsible for some of the proinflammatory actions of NO• (15).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Underwood, J. C. E. (1992) Pathology. 1st ed. Churchill Livingstone, Edinburgh.
Hibbs, Jr, J. B., Taintor, R. R., Vavrin, Z., Rachlin, E. M. (1988) Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem. Biophy. Res. Commun. 157, 87–94.
Nathan, C. F. and Hibbs, Jr., J. B. (1991) Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3, 65–70.
Frears, E. R., Zhang, Z., Blake, D. R., O’Connell, J. P., and Winyard, P. G. (1996) Inactivation of tissue inhibitor of metalloproteinase-1 by peroxynitrite. FEBS Lett. 381, 21–24.
Rubbo, H., Parthasarathy, S., Barnes, S., Kirk, M., Kalyanaraman, B., and Freeman, B. A. (1995) Nitric oxide inhibition of lipoxygenase-dependent liposome and low-density lipoprotein oxidation: termination of radical chain propagation reactions and formation of nitrogen-containing oxidized lipid derivatives. Arch. Biochem. Biophys. 324, 15–25.
Salvemini, D. and Masferrer, J. L. (1996) Interactions of nitric oxide with cyclooxygenase: in vitro, ex vivo, and in vivo studies. Methods Enzymol. 269, 12–25.
Maccarrone, M., Corasaniti, M. T., Guerrieri, P., Nistico, G., and Finazzi, A.A. (1996) Nitric oxide-donor compounds inhibit lipoxygenase activity. Biochem. Biophys. Res. Commun. 219, 128–133.
McInnes, I. B., Leung, B. P., Field, M., Wei, X. Q., Huang, F. P., Sturrock, R.D., et al. (1996) Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J. Exp. Med. 184, 1519–1524.
Connelly, L., Palacios-Callender, M., Ameixa, C., Moncada, S., and Hobbs, A. J. (2001) Biphasic regulation of NF-kappa B activity underlies the pro-and anti-inflammatory actions of nitric oxide. J. Immunol. 166, 3873–3881.
Kuo, H. P., Wang, C. H., Huang, K. S., Lin, H. C., Yu, C. T., Liu, C. Y., et al. (2000) Nitric oxide modulates interleukin-1beta and tumor necrosis factor-alpha synthesis by alveolar macrophages in pulmonary tuberculosis. Am. J. Respirat. Crit. Care Med. 161, 192–199.
Katsuyama, K., Shichiri, M., Marumo, F., and Hirata, Y. (1998) NO• inhibits cytokine-induced iNOS expression and NF-kappaB activation by interfering with phosphorylation and degradation of I kappaB-alpha. Arterioscler. Thromb. Vas. Biol. 18, 1796–1802.
Peng, H. B., Libby, P., and Liao, J. K. (1995) Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. J. Biol. Chem. 270, 14,214–14,219.
Spiecker, M., Darius, H., Kaboth, K., Hubner, F., and Liao, J. K. (1998) Differential regulation of endothelial cell adhesion molecule expression by nitric oxide donors and antioxidants. J. Leuko. Biol. 63, 732–739.
Arnal, J. F., Dinh-Xuan, A. T., Pueyo, M., Darblade, B., and Rami, J. (1999) Endothelium-derived nitric oxide and vascular physiology and pathology. Cell Mol. Life Sci. 55, 1078–1087.
Groves, J. T. (1999) Peroxynitrite: reactive, invasive and enigmatic. Curr. Opin. Chem. Biol. 3, 226–235.
Feelisch, M. and Stamler, J. S. (1996) Methods in Nitric Oxide Research. Wiley, UK.
Vallance, P. and Chan, N. (2001) Endothelial function and nitric oxide: clinical relevance. Heart 85, 342–350.
Prast, H. and Philippu, A. (2001) Nitric oxide as modulator of neuronal function. Progress Neurobiol. 64, 51–68.
Zhang, Z., Naughton, D., Winyard, P. G., Benjamin, N., Blake, D. R., and Symons M. C. (1998) Generation of nitric oxide by a nitrite reductase activity of xanthine oxidase: a potential pathway for nitric oxide formation in the absence of nitric oxide synthase activity. Biochem. Biophys. Res. Commun. 249, 767–772.
Millar, T. M., Stevens, C. R., Benjamin, N., Eisenthal, R., Harrison, R., and Blake, D. R. (1998) Xanthine oxidoreductase catalyses the reduction of nitrates and nitrite to nitric oxide under hypoxic conditions. FEBS Letts. 427, 225–228.
Halliwell, B. and Gutteridge, J. M. C. (1999) Free radicals in biology and medicine. 3rd ed. Oxford University Press, Oxford.
Nazhat, N. B., Saadalla-Nazhat, R. A., Fairburn, K., Jones, P., Blake, D. R., Nielsen, B. R., et al. (1999) Nitrite determination in human plasma and synovial fluid using reation of nitric oxide with 3,5-dibromo-4-nitrosbenzene sulfonate (DBNBS). Biochim. Biophys. Acta 1427, 276–286.
Ueki, Y., Miyake, S., Tominaga, Y., and Eguchi, K. (1996) Increased nitric oxide levels in patients with rheumatoid arthritis. J. Rheumatol. 23, 230–236.
Farrell, A. J., Blake, D. R., Palmer, R. M., and Moncada, S. (1992) Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases. Ann. Rheum. Dis. 51, 1219–1222.
Brundin L., Svenungsson E., Morcos E., Andersson M., Olsson T., Lundberg I., et al. (1998) Central nervous system nitric oxide formation in cerebral systemic lupus erythematosus. Ann. Neurol. 44, 704–706.
Giovannoni, G., Land, J. M., Keir, G., Thompson, E. J., and Heales, S. J. (1997) Adaptation of the nitrate reductase and Griess reaction methods for the measurement of serum nitrate plus nitrite levels. Ann. Clin. Biochem. 34, 193–198.
El Menyawi, I., Looareesuwan, S., Knapp, S., Thalhammer, F., Stoiser, B., and Burgmann, H. (1998) Measurement of serum nitrite/nitrate concentrations using high-performance liquid chromatography. J. Chromatog. B., Biomed. Sci. Appl. 706, 347–351.
Tsikas, D., Gutzki, F. M., Rossa, S., Bauer, H., Neumann, C., Dockendorff, K., et al. (1997) Measurement of nitrite and nitrate in biological fluids by gas chromatography-mass spectrometry and by the Griess assay: problems with the Griess assay-solutions by gas chromatography-mass spectrometry. Anal. Biochem. 244, 208–220.
Chung, S. J. and Fung, H. L. (1992) Removal of ammonia interference in the redox chemiluminescence assay of nitric-oxide. Anal. Lett. 25, 2021–2036.
Davies, C. A., Perrett, D., Zhang, Z., Nielsen, B. R., Blake, D. R., and Winyard, P. G. (1999) Simultaneous analysis of nitrite, nitrate and the nicotinamide nucleotides by capillary electrophoresis: Application to biochemical studies and human extracellular fluids. Electrophoresis 20, 2111–2117.
Moshage, H., Kok, B., Huizenga, J. R., and Jansen, P. L. (1995) Nitrite and nitrate determinations in plasma: a critical evaluation. Clin. Chem. 41, 892–896.
Hirano, T., Matsuda, T., Turner, M., Miyasaka, N., Buchan, G., Tang, B., et al. (1988) Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur. J. Immunol. 18, 1797–1801.
Bergroth, V., Zvanifler, N. J., and Firestein, G. S. (1990) Cytokines in chronic inflammatory arthritis. III. Rheumatoid arthritis monocytes are not usually sensitive to γ-interferon, but have defective γ-interferon-mediated HA-DQ and HLA-DR induction. Arthr. Rheum. 32, 1074–1079.
Firestein, G. S., Alvaro-Gracia, J. M., and Maki, M. (1990) Quantitative analysis of cytokine gene expression in rheumatoid arthritis. J Immunol. 144, 3347–3353.
Sakurai, H., Kohsaka, H., Liu, M. F, Higashiyama, H., Hirata, Y., Kanno, K., et al. (1995) Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritis. J. Clin. Invest. 96, 2357–2363.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc.
About this protocol
Cite this protocol
Davies, C.A., Rocks, S.A., O’ Shaughnessy, M.C., Perrett, D., Winyard, P.G. (2003). Analysis of Nitrite and Nitrate in the Study of Inflammation. In: Winyard, P.G., Willoughby, D.A. (eds) Inflammation Protocols. Methods in Molecular Biology, vol 225. Humana Press. https://doi.org/10.1385/1-59259-374-7:305
Download citation
DOI: https://doi.org/10.1385/1-59259-374-7:305
Publisher Name: Humana Press
Print ISBN: 978-0-89603-970-4
Online ISBN: 978-1-59259-374-3
eBook Packages: Springer Protocols